plerixafor has been researched along with Experimental Radiation Injuries in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerman, JJH; Beeman, SC; Duan, C; Engelbach, JA; Garbow, JR; Ge, X; Perez-Torres, CJ; Rich, KM; Tsien, CI; Yang, R; Yuan, L | 1 |
| Gao, H; Hao, C; Hong, S; Nayra, C; Rojas, M; Shim, H; Shu, HK; Torres-Gonzalez, E; Xu, K; Yoon, Y | 1 |
| Ai, GP; Cheng, TM; Dong, SW; Li, N; Ran, XZ; Shen, Y; Su, YP; Xu, H; Zong, ZW | 1 |
| Brown, SL; Jenrow, KA; Kim, JH; Kolozsvary, A | 1 |
4 other study(ies) available for plerixafor and Experimental Radiation Injuries
| Article | Year |
|---|---|
Inhibitors of HIF-1α and CXCR4 Mitigate the Development of Radiation Necrosis in Mouse Brain.
Topics: Animals; Benzylamines; Brain; Cyclams; Disease Models, Animal; Disease Progression; Female; Heterocyclic Compounds; Hypoxia-Inducible Factor 1, alpha Subunit; Magnetic Resonance Imaging; Mice; Mice, Inbred BALB C; Necrosis; Radiation Injuries, Experimental; Receptors, CXCR4; Topotecan | 2018 |
Inhibition of the CXCL12/CXCR4-axis as preventive therapy for radiation-induced pulmonary fibrosis.
Topics: Animals; Benzylamines; Chemokine CXCL12; Cyclams; Disease Models, Animal; Female; Heterocyclic Compounds; Lung; Mesenchymal Stem Cells; Mice; Pulmonary Fibrosis; Pyrimidines; Radiation Injuries; Radiation Injuries, Experimental; Receptors, CXCR4; Tomography, X-Ray Computed | 2013 |
Recruitment of transplanted dermal multipotent stem cells to sites of injury in rats with combined radiation and wound injury by interaction of SDF-1 and CXCR4.
Topics: Animals; Benzylamines; Bone Marrow; Cells, Cultured; Chemokine CXCL12; Chemotaxis; Cyclams; Dermis; Female; Heterocyclic Compounds; Male; Multipotent Stem Cells; Radiation Injuries, Experimental; Rats; Rats, Wistar; Receptors, CXCR4; Skin; Up-Regulation; Wound Healing | 2008 |
Plerixafor, a CXCR4 antagonist, mitigates skin radiation-induced injury in mice.
Topics: Animals; Benzylamines; Cyclams; Dose-Response Relationship, Radiation; Heterocyclic Compounds; Mice; Mice, Inbred C57BL; Radiation Injuries, Experimental; Radiation-Protective Agents; Receptors, CXCR4; Skin; Time Factors | 2012 |